Related Experiment Videos
Isolation of human minor histocompatibility peptides
1Department of Immunology, University of Tokyo, Japan.
International Immunology
|February 1, 1992
Summary
Minor histocompatibility antigens cause transplant rejection even with matched HLA genes. Researchers isolated specific hmH peptides presented by HLA-B35 molecules, revealing MHC class I
Area of Science:
- Immunology
- Transplantation Immunology
- Molecular Biology
Background:
- Minor histocompatibility (hmH) antigens are a significant barrier to successful organ and bone marrow transplantation, leading to graft rejection and graft-versus-host disease.
- These hmH antigens are specifically recognized by T cells, posing a challenge for transplantation even when donors and recipients are matched for human leukocyte antigen (HLA) genes.
Purpose of the Study:
- To isolate and characterize hmH peptides responsible for T cell-mediated rejection.
- To investigate the role of major histocompatibility complex (MHC) class I molecules in the natural processing and presentation of hmH peptides.
Main Methods:
- Isolation of hmH peptides using acid elution from a donor-derived B cell line and an HLA-B35 transfected human B cell line.
- Characterization of T cell recognition using a specific HLA-B35 restricted cytotoxic T lymphocyte (CTL) clone derived from a patient experiencing transplant rejection.
- Analysis of peptide presentation by various HLA class I transfectant cells.
Main Results:
- Successful isolation of naturally occurring hmH peptides recognized by an HLA-B35 restricted CTL clone.
- Demonstration that MHC class I molecules play a crucial role in determining which peptides are naturally processed and presented to T cells.
Conclusions:
- MHC class I molecules intrinsically dictate the repertoire of naturally processed and presented peptides, including hmH antigens.
- Understanding hmH peptide presentation by MHC class I is critical for improving transplantation outcomes and mitigating rejection.